Transcript • May. 7, 2026 9:00 PM • The Joint Corp. (JYNT)
Transcript
May. 7, 2026 9:00 PM
The Joint Corp. (JYNT)
Sanjeev Razan: well as new franchisees being attracted to the brand. Once we publish our franchise disclosure document, we will be able to share some of these numbers more publicly with potential franchisees and optimistic about the impact that we'll have on our pipeline. Understood. Thanks for taking my questions, guys.
Conference Operator: As a reminder, if you have a question, please press star 1. The next question comes from George Kelly from Ross Capital. Please go ahead.
George Kelly: Hi, everyone. Thanks for taking my questions. First one is on pricing. Maybe I missed it in your prepared remarks, but did you settle on a $10 pricing increase?
Not Provided: Going forward, yeah, we were leveraging a $10 price increase more. And looking at the analytics and working with the operators, that is the preferred increase that we have right now.
George Kelly: Okay. But you expect to take some kind of price across the entire base by year end?
Conference Operator: That's correct.
George Kelly: Okay. And then second question, you mentioned about the four consecutive months of improved active members. Could you give, like, just a sort of comp trend over that same time frame? And, like, where did you exit the quarter or what kind of comp growth did you generate? I think you said it was slightly negative, but could you just quantify where comps are trending currently?
Not Provided: Yeah. So to end the quarter, you know, they were similar to, you know, the full quarter of negative 4.2. They were right in that range. However, once we got into April, you know, we did see some improvement. And so, quarterly, they were running about negative 3%. And so, as Sanjeev mentioned, we're seeing some good signs and improvement, you know, month-over-month improvement in our active member growth. And that improvement is better trends in attracting new patients, the conversion of those patients, and then also improvement on our patient retention. And so those three areas are what we look at as KPIs to drive active member growth and we've seen improvement in all three.
George Kelly: Okay. Okay. And then two other quick ones. Back to the prior question about your GNA, kind of go forward GNA. So if I look at the 7.1 in Q1, you mentioned that there was 300,000 of non-recurring I think post-refranchising 300K that's expected to come out. Was that a quarterly number? And then the second question on G&A is there was also a $600,000 restructuring charge in the quarter, and did that fully hit G&A? So if I take those two amounts out, is the kind of real go-forward G&A run rate somewhere in the kind of low six range?
Not Provided: Yeah, so the $300,000, you're right, that was. a quarterly number, which will go away, you know, once we're fully re-franchised. And then the restructuring, yeah, most of that, you know, was in G&A and then, you know, was added back for just to keep it up.
George Kelly: Okay, okay. And then last question from me. You mentioned the FTD. and your sort of optimism around messaging that whenever that comes out, I presume shortly. I guess if you could, the one question I had is just on floor wall margin. I don't know if you can talk to it at all or give any kind of input. Has that stabilized? Do you still hear a lot of input from your franchisees about labor inflation and other aspects of inflation, or do you have a sense that that four-wall margin is holding in?
Sanjeev Razan: Yeah. So, George, two things. One, of course, the FDD is due out shortly, so prospective franchisees and anybody who looks at it will get a transparency to the item 19 and some of the numbers over there. I think what we're seeing now is stabilization for quite some time. I think by some time, I mean several months, almost a year, the labor wage inflation that we were seeing in this business has stabilized and that is not growing at the same rate that it was in that post-pandemic period. So that is definitely our, I would say the input cost structure is relatively stable and that is why as active members keep growing and our ability to transfer some of that cost that we have not transferred onto consumers we found with these 300 clinics where we've taken the price increases like there's really been no impact to conversion or retention so we're optimistic that that will help start to shore up some of the unit level economics as the new pricing starts to kick in early quarter three.
George Kelly: Okay. I appreciate it. Thank you. Thank you.
Conference Operator: This concludes our question and answer session. I would like to turn the conference back over to Sanjeev Razan for closing remarks.
Sanjeev Razan: Thank you all for joining us today. Have a great day and remember at the joint We always have your back.
Conference Operator: The conference is now concluded. Thank you for attending today's presentation. You may now disconnect.
